课题基金 / 基金详情

Immunotoxins based on the IgG response to autologous antigens in cancer patients

Immunotoxins based on the IgG response to autologous antigens in cancer patients
基于癌症患者对自体抗原的 IgG 反应的免疫毒素
批准号:
9101634
负责人:
SCOTT Kendall DESSAIN
金额:
$19.9万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2018-03-31

项目摘要

项目成果

SCOTT Kendall DESSAIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer death in the United States, but the promise of therapies based on monoclonal antibodies (mAbs) has been unrealized due to the lack of known antibody targets specific for lung cancer cells. This research will address this need by characterizing three new lung cancer-specific mAbs that were cloned from patients with cancer and have shown cytotoxic activity in vitro when converted into antibody drug conjugates. We will convert them into immunotoxins and test them for and determine their specificity, safety and efficacy against lung cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comprehensive functional assesment of the human antibody response to Enterovirus 71
Immunotoxins based on the IgG response to autologous antigens in cancer patients
Human Monoclonal Antibodies that Bind Botulinum Toxins
Human Monoclonal Antibodies that Bind Botulinum Toxins
海外基金